Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2022-11-01
2023-10-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Cardiac surgery patients is a population high exposed to plastics. This observational study will obtain biological samples of cardiac surgery patients as a reference and vulnerable group of individuals highly exposed to microplastics and potentially more susceptible.
The objective of this research is to be able to detect microplastics on blood and operation samples of cardiac surgery patients as well as their potential genotoxic and immunological damage.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on the Protective Effect of RIPC in Patients Undergoing Cardiac Surgery.
NCT04433468
Management Practices and the Risk of Infection Following Cardiac Surgery
NCT01089712
Evaluation of Peri-operative Risk Factors for Surgery Site Infection in Cardiac Surgery
NCT02392936
Reversal of Obesity Cardiomyopathy
NCT01372397
Micro- and Macro-Circulation in Cardiac Surgery Patients
NCT05706545
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Detection of microplastics/nanoplastics in heart tissue and the blood of patients undergoing cardiac surgery
Microplastics
Detection of microplastics as a yes/no value
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microplastics
Detection of microplastics as a yes/no value
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective cardiac surgery
Exclusion Criteria
* Previous cardiac surgery
* Previous severe liver disease
* Pregnant or planning to become pregnant
* Have a malignant tumor
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kun Hua
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kun Hua
Deputy Chief Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kun Hua
Role: STUDY_CHAIR
Beijing Anzhen Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
default
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.